The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  De Souza, Devandir Antonio ^a   Santana, Ana Carolina ^a   Da Silva, Elaine Zayas Marcelino ^a   Oliver, Constance ^a   Jamur, Maria Celia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIG ENDOTHELIN 1; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE A3; CHEMOKINE; CHYMASE; CYCLOOXYGENASE 2 INHIBITOR; GELATINASE B; INOSINATE DEHYDROGENASE; INTERLEUKIN 6; THROMBIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALLERGIC REACTION; AMINO ACID SEQUENCE; ANGIOGENESIS; CANCER CELL; CELL HETEROGENEITY; CELL SPECIFICITY; HUMAN; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; REVIEW; SECRETORY GRANULE; TISSUE DISTRIBUTION; TUMOR ANGIOGENESIS; TUMOR GROWTH; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY;

CHYMASES; HUMANS; MAST CELLS; MOLECULAR TARGETED THERAPY; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TRYPTASES;

EID: 84934910434     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/142359     Document Type: Review

References (169)

1. J. Folkman and Y. Shing, "Angiogenesis", The Journal of Biological Chemistry, vol. 267, no. 16, pp. 10931-10934, 1992.
2. T. O. Daniel and D. Abrahamson, "Endothelial signal integration in vascular assembly", Annual Review of Physiology, vol. 62, pp. 649-671, 2000.
3. D. Ribatti, "Genetic and epigenetic mechanisms in the early development of the vascular system", Journal of Anatomy, vol. 208, no. 2, pp. 139-152, 2006.
4. D. Ribatti and E. Crivellato, "Mast cells, angiogenesis, and tumour growth", Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1822, no. 1, pp. 2-8, 2012.
5. D. Hanahan and J. Folkman, "Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis", Cell, vol. 86, no. 3, pp. 353-364, 1996.
6. M. L. Iruela-Arispe and H. F. Dvorak, "Angiogenesis: a dynamic balance of stimulators and inhibitors", Thrombosis and Haemostasis, vol. 78, no. 1, pp. 672-677, 1997.
7. M. Sawatsubashi, T. Yamada, N. Fukushima, H. Mizokami, O. Tokunaga, and T. Shin, "Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma", Virchows Archiv, vol. 436, no. 3, pp. 243-248, 2000.
8. J. Talreja, M. H. Kabir, M. B. Filla, D. J. Stechschulte, and K. N. Dileepan, "Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Grampositive and Gram-negative bacterial cell wall components", Immunology, vol. 113, no. 2, pp. 224-233, 2004.
9. B. Hobson and J. Denekamp, "Endothelial proliferation in tumours and normal tissues: continuous labelling studies", British Journal of Cancer, vol. 49, no. 4, pp. 405-413, 1984.
10. P. A. D'Amore and R. W. Thompson, "Mechanisms of angiogenesis", Annual Review of Physiology, vol. 49, pp. 453-464, 1987.
11. A. Le Querrec, D. Duval, and G. Tobelem, "Tumour angiogenesis", Bailliere's Clinical Haematology, vol. 6, no. 3, pp. 711-730, 1993.
12. M. Potente, H. Gerhardt, and P. Carmeliet, "Basic and therapeutic aspects of angiogenesis", Cell, vol. 146, no. 6, pp. 873-887, 2011.
13. E. Goldmann, "The growth of malignant disease in man and the lower animals, with special reference to the vascular system", Proceedings of the Royal Society of Medicine, Surgery Section, vol. 1, pp. 1-13, 1908.
14. J. Folkman, "Tumor angiogenesis: therapeutic implications", The New England Journal of Medicine, vol. 285, no. 21, pp. 1182-1186, 1971.
15. G. Ranieri, C. D. Gadaleta, R. Patruno et al., "A model of study for human cancer: spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies", Critical Reviews in Oncology/Hematology, vol. 88, no. 1, pp. 187-197, 2013.
16. G. Ranieri, M. Pantaleo, M. Piccinno et al., "Tyrosine kinase inhibitors (TKIs) in human and pet tumours with special reference to breast cancer: a comparative review", Critical Reviews in Oncology/Hematology, vol. 88, no. 2, pp. 293-308, 2013.
17. B. Al-Husein, M. Abdalla, M. Trepte, D. L. De Remer, and P. R. Somanath, "Antiangiogenic therapy for cancer: an update", Pharmacotherapy, vol. 32, no. 12, pp. 1095-1111, 2012.
18. A. W. Griffioen and G. Molema, "Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation", Pharmacological Reviews, vol. 52, no. 2, pp. 237-268, 2000.
19. P. Carmeliet and R. K. Jain, "Molecular mechanisms and clinical applications of angiogenesis", Nature, vol. 473, no. 7347, pp. 298-307, 2011.
20. F. Moccia, S. Dragoni, V. Poletto et al., "Orai1 and transient receptor potential channels as novel molecular targets to impair tumor neovascularization in renal cell carcinoma and other malignancies", Anti-Cancer Agents in Medicinal Chemistry, vol. 14, no. 2, pp. 296-312, 2014.
21. T. Marichal, M. Tsai, and S. J. Galli, "Mast cells: potential positive and negative roles in tumor biology", Cancer Immunology Research, vol. 1, no. 5, pp. 269-279, 2013.
22. D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next generation", Cell, vol. 144, no. 5, pp. 646-674, 2011.
23. D. Ribatti and E. Crivellato, "Immune cells and angiogenesis", Journal of Cellular and Molecular Medicine, vol. 13, no. 9, pp. 2822-2833, 2009.
24. E. Z. M. Da Silva, M. C. Jamur, and C. Oliver, "Mast cell function: a new vision of an old cell", Journal of Histochemistry & Cytochemistry, vol. 62, no. 10, pp. 698-738, 2014.
25. S. J. Galli, J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. M. Williams, and M. Tsai, "Mast cells as 'tunable' effector and immunoregulatory cells: recent advances", Annual Review of Immunology, vol. 23, pp. 749-786, 2005.
26. M. F. Gurish and K. F. Austen, "Developmental origin and functional specialization of mast cell subsets", Immunity, vol. 37, no. 1, pp. 25-33, 2012.
27. M. F. Gurish and J. A. Boyce, "Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell", The Journal of Allergy and Clinical Immunology, vol. 117, no. 6, pp. 1285-1291, 2006.
28. K. D. Stone, C. Prussin, and D. D. Metcalfe, "IgE, mast cells, basophils, and eosinophils", Journal of Allergy and Clinical Immunology, vol. 125, no. 2, supplement 2, pp. S73-S80, 2010.
29. M. C. Jamur and C. Oliver, "Origin, maturation and recruitment of mast cell precursors", Frontiers in Bioscience, vol. 3, no. 4, pp. 1390-1406, 2011.
30. D. D. Metcalfe, R. D. Peavy, and A. M. Gilfillan, "Mechanisms of mast cell signaling in anaphylaxis", Journal of Allergy and Clinical Immunology, vol. 124, no. 4, pp. 639-646, 647-638, 2009.
31. H. R. Katz, M. B. Raizman, C. S. Gartner, H. C. Scott, A. C. Benson, and K. F. Austen, "Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells", Journal of Immunology, vol. 148, no. 3, pp. 868-871, 1992.
32. J. W. Coleman, M. R. Holliday, I. Kimber, K. M. Zsebo, and S. J. Galli, "Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4", The Journal of Immunology, vol. 150, no. 2, pp. 556-562, 1993.
33. S. J. Galli, A. Iemura, D. S. Garlick, C. Gamba-Vitalo, K. M. Zsebo, and R. G. Andrews, "Reversible expansion of primate mast cell populations in vivo by stem cell factor", The Journal of Clinical Investigation, vol. 91, no. 1, pp. 148-152, 1993.
34. V. Supajatura, H. Ushio, A. Nakao et al., "Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity", Journal of Clinical Investigation, vol. 109, no. 10, pp. 1351-1359, 2002.
35. S. J. Galli, S. Nakae, and M. Tsai, "Mast cells in the development of adaptive immune responses", Nature Immunology, vol. 6, no. 2, pp. 135-142, 2005.
36. R. T. Venkatesha, E. B. Thangam, A. K. Zaidi, and H. Ali, "Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase", Molecular Immunology, vol. 42, no. 5, pp. 581-587, 2005.
37. S. J. Galli and M. Tsai, "Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis", Journal of Dermatological Science, vol. 49, no. 1, pp. 7-19, 2008.
38. H. R. Katz, J. P. Arm, A. C. Benson, and K. F. Austen, "Maturation-related changes in the expression of FcγRII and FcγRIII on mouse mast cells derived in vitro and in vivo", The Journal of Immunology, vol. 145, no. 10, pp. 3412-3417, 1990.
39. G. Pejler, M. Åbrink, M. Ringvall, and S. Wernersson, "Mast cell proteases", Advances in Immunology, vol. 95, pp. 167-255, 2007.
40. L. B. Schwartz and T. R. Bradford, "Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer", Journal of Biological Chemistry, vol. 261, no. 16, pp. 7372-7379, 1986.
41. L. B. Schwartz, A. M. A. Irani, K. Roller, M. C. Castells, and N. M. Schechter, "Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells", Journal of Immunology, vol. 138, no. 8, pp. 2611-2615, 1987.
42. C. Huang, G. Morales, A. Vagi et al., "Formation of enzymatically active, homotypic, and heterotypic tetramers of mouse mast cell tryptases. Dependence on a conserved Trp-rich domain on the surface", Journal of Biological Chemistry, vol. 275, no. 1, pp. 351-358, 2000.
43. G. Pejler, S. D. Knight, F. Henningsson, and S. Wernersson, "Novel insights into the biological function of mast cell carboxypeptidase A", Trends in Immunology, vol. 30, no. 8, pp. 401-408, 2009.
44. F. R. Melo, I. Waern, E. Rönnberg et al., "A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway", The Journal of Biological Chemistry, vol. 286, no. 7, pp. 5423-5433, 2011.
45. M. Åbrink, M. Grujic, and G. Pejler, "Serglycin is essential for maturation of mast cell secretory granule", The Journal of Biological Chemistry, vol. 279, no. 39, pp. 40897-40905, 2004.
46. T. Braga, M. Grujic, A. Lukinius, L. Hellman, M. Åbrink, and G. Pejler, "Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells", Biochemical Journal, vol. 403, no. 1, pp. 49-57, 2007.
47. S. J. Galli, N. Borregaard, and T. A. Wynn, "Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils", Nature Immunology, vol. 12, no. 11, pp. 1035-1044, 2011.
48. J. P. Abonia, C. Blanchard, B. B. Butz et al., "Involvement of mast cells in eosinophilic esophagitis", Journal of Allergy and Clinical Immunology, vol. 126, no. 1, pp. 140-149, 2010.
49. H2-high asthma", The Journal of Allergy and Clinical Immunology, vol. 125, no. 5, pp. 1046.e8-1053.e8, 2010.
50. R. L. Stevens, D. S. Friend, H. P. Mcneil, V. Schiller, N. Ghildyal, and K. F. Austen, "Strain-specific and tissue-specific expression of mouse mast cell secretory granule proteases", Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 1, pp. 128-132, 1994.
51. M. F. Gurish, W. S. Pear, R. L. Stevens et al., "Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitor", Immunity, vol. 3, no. 2, pp. 175-186, 1995.
52. D. S. Friend, N. Ghildyal, K. F. Austen, M. F. Gurish, R. Matsumoto, and R. L. Stevens, "Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype", Journal of Cell Biology, vol. 135, no. 1, pp. 279-290, 1996.
53. W. Xing, K. F. Austen, M. F. Gurish, and T. G. Jones, "Protease phenotype of constitutive connective tissue and of induced mucosal mast cells in mice is regulated by the tissue", Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 34, pp. 14210-14215, 2011.
54. H. P. McNeil, K. Shin, I. K. Campbell et al., "The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis", Arthritis and Rheumatism, vol. 58, no. 8, pp. 2338-2346, 2008.
55. K. Shin, G. F. M. Watts, H. C. Oettgen et al., "Mouse mast cell tryptase mMCP-6 Is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection", Journal of Immunology, vol. 180, no. 7, pp. 4885-4891, 2008.
56. Q. Sun, W. Li, R. She et al., "Evidence for a role of mast cells in the mucosal injury induced by Newcastle disease virus", Poultry Science, vol. 88, no. 3, pp. 554-561, 2009.
57. L. Scandiuzzi, W. Beghdadi, E. Daugas et al., "Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis", Journal of Immunology, vol. 185, no. 1, pp. 624-633, 2010.
58. A. Lambiase, A. Micera, and S. Bonini, "Multiple action agents and the eye: do they really stabilize mast cells?" Current Opinion in Allergy and Clinical Immunology, vol. 9, no. 5, pp. 454-465, 2009.
59. D. A. De Souza Jr., V. D. Toso, M. R. D. C. Campos, V. S. Lara, C. Oliver, and M. C. Jamur, "Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression", PLoS ONE, vol. 7, no. 7, Article ID e40790, 2012.
60. P. Ehrlich, Beiträge zur Theorie und Praxis der Histologischen F ärbung, 1878.
61. S. Ch'ng, R. A. Wallis, L. Yuan, P. F. Davis, and S. T. Tan, "Mast cells and cutaneous malignancies", Modern Pathology, vol. 19, no. 1, pp. 149-159, 2006.
62. M. Gulubova and T. Vlaykova, "Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer", Journal of Gastroenterology and Hepatology, vol. 24, no. 7, pp. 1265-1275, 2009.
63. G. Ranieri, M. Ammendola, R. Patruno et al., "Tryptasepositive mast cells correlate with angiogenesis in early breast cancer patients", International Journal of Oncology, vol. 35, no. 1, pp. 115-120, 2009.
64. A. Mangia, A. Malfettone, R. Rossi et al., "Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation", Histopathology, vol. 58, no. 7, pp. 1096-1106, 2011.
65. I. Takanami, K. Takeuchi, and M. Naruke, "Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma", Cancer, vol. 88, no. 12, pp. 2686-2692, 2000.
66. S. Dabiri, D. Huntsman, N. Makretsov et al., "The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis", Modern Pathology, vol. 17, no. 6, pp. 690-695, 2004.
67. P. Conti, M. L. Castellani, D. Kempuraj et al., "Role of mast cells in tumor growth", Annals of Clinical and Laboratory Science, vol. 37, no. 4, pp. 315-322, 2007.
68. B. L. Gruber, M. J. Marchese, and R. Kew, "Angiogenic factors stimulate mast-cell migration", Blood, vol. 86, no. 7, pp. 2488-2493, 1995.
69. B. Huang, Z. Lei, G.-M. Zhang et al., "SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment", Blood, vol. 112, no. 4, pp. 1269-1279, 2008.
70. L. Beńitez-Bribiesca, A. Wong, D. Utrera, and E. Castellanos, "The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix", Journal of Histochemistry and Cytochemistry, vol. 49, no. 8, pp. 1061-1062, 2001.
71. M. P. Wymann, K. Björklöf, R. Calvez et al., "Phosphoinositide 3-kinase γ: a key modulator in inflammation and allergy", Biochemical Society Transactions, vol. 31, part 1, pp. 275-280, 2003.
72. M. A. Grimbaldeston, A. L. Pearce, B. O. Robertson et al., "Association between melanoma and dermal mast cell prevalence in sun-unexposed skin", British Journal of Dermatology, vol. 150, no. 5, pp. 895-903, 2004.
73. D. Ribatti, N. Finato, E. Crivellato et al., "Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer", The American Journal of Obstetrics and Gynecology, vol. 193, no. 6, pp. 1961-1965, 2005.
74. M. Yoshii, A. Jikuhara, S. Mori et al., "Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners", Journal of Pharmacological Sciences, vol. 98, no. 4, pp. 450-458, 2005.
75. N. C. Diaconu, R. Kaminska, A. Naukkarinen, R. J. Harvima, and I. T. Harvima, "The increase in tryptase- and chymasepositive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma", Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 7, pp. 908-915, 2007.
76. N. Nonomura, H. Takayama, K. Nishimura et al., "Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer", British Journal of Cancer, vol. 97, no. 7, pp. 952-956, 2007.
77. A. Fleischmann, T. Schlomm, J. Köllermann et al., "Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis", Prostate, vol. 69, no. 9, pp. 976-981, 2009.
78. M. J. Carlini, M. C. L. Dalurzo, J. M. Lastiri et al., "Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance", Human Pathology, vol. 41, no. 5, pp. 697-705, 2010.
79. A. Johansson, S. Rudolfsson, P. Hammarsten et al., "Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy", The American Journal of Pathology, vol. 177, no. 2, pp. 1031-1041, 2010.
80. D. Ribatti, D. Guidolin, A. Marzullo et al., "Mast cells and angiogenesis in gastric carcinoma", International Journal of Experimental Pathology, vol. 91, no. 4, pp. 350-356, 2010.
81. G. Dyduch, K. Kaczmarczyk, and K. Okoń, "Mast cells and cancer: enemies or allies?" Polish Journal of Pathology, vol. 63, no. 1, pp. 1-7, 2012.
82. D. Ribatti, A. Vacca, B. Nico, E. Crivellato, L. Roncali, and F. Dammacco, "The role of mast cells in tumour angiogenesis", British Journal of Haematology, vol. 115, no. 3, pp. 514-521, 2001.
83. E. Crivellato, C. A. Beltrami, F. Mallardi, and D. Ribatti, "The mast cell: an active participant or an innocent bystander?" Histology and Histopathology, vol. 19, no. 1, pp. 259-270, 2004.
84. 2 production in human coronary artery endothelial cells", Journal of Immunology, vol. 179, no. 11, pp. 7899-7906, 2007.
85. M. Muramatsu, J. Katada, M. Hattori, I. Hayashi, and M. Majima, "Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas", European Journal of Pharmacology, vol. 402, no. 1-2, pp. 181-191, 2000.
86. M. Muramatsu, J. Katada, I. Hayashi, and M. Majima, "Chymase as a proangiogenic factor. A possible involvement of chymaseangiotensin-dependent pathway in the hamster sponge angiogenesis model", The Journal of Biological Chemistry, vol. 275, no. 8, pp. 5545-5552, 2000.
87. T. Tth, R. Tth-Jakatics, S. Jimi, S. Takebayashi, and N. Kawamoto, "Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor", Human Pathology, vol. 31, no. 8, pp. 955-960, 2000.
88. K. Norrby, "Mast cells and angiogenesis", Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 110, no. 5, pp. 355-371, 2002.
89. I. Feoktistov, S. Ryzhov, A. E. Goldstein, and I. Biaggioni, "Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors", Circulation Research, vol. 92, no. 5, pp. 485-492, 2003.
90. M. Juczewska and L. Chyczewski, "Angiogenesis in cancer", Roczniki Akademii Medycznej w Bialymstoku, vol. 42, supplement 1, pp. 86-100, 1997.
91. L. B. Schwartz, R. A. Lewis, and K. F. Austen, "Tryptase from human pulmonary mast cells. Purification and characterization.", The Journal of Biological Chemistry, vol. 256, no. 22, pp. 11939-11943, 1981.
92. L. B. Schwartz, "Tryptase, a mediator of human mast cells", Journal of Allergy and Clinical Immunology, vol. 86, no. 4, pp. 594-598, 1990.
93. V. Payne and P. C. A. Kam, "Mast cell tryptase: a review of its physiology and clinical significance", Anaesthesia, vol. 59, no. 7, pp. 695-703, 2004.
94. G. Pejler, E. Rönnberg, I. Waern, and S. Wernersson, "Mast cell proteases: multifaceted regulators of inflammatory disease", Blood, vol. 115, no. 24, pp. 4981-4990, 2010.
95. H.-Z. Xia, C. L. Kepley, K. Sakai, J. Chelliah, A.-M. A. Irani, and L. B. Schwartz, "Quantitation of tryptase, chymase, FcεRlα, and FcεRlγ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction", Journal of Immunology, vol. 154, no. 10, pp. 5472-5480, 1995.
96. S. Wernersson and G. Pejler, "Mast cell secretory granules: armed for battle", Nature Reviews Immunology, vol. 14, no. 7, pp. 478-494, 2014.
97. J. P. Kankkunen, I. T. Harvima, and A. Naukkarinen, "Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions", International Journal of Cancer, vol. 72, no. 3, pp. 385-388, 1997.
98. A. Imada, N. Shijubo, H. Kojima, and S. Abe, "Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma", European Respiratory Journal, vol. 15, no. 6, pp. 1087-1093, 2000.
99. B. Nico, A. Marzullo, P. Corsi, A. Vacca, L. Roncali, and D. Ribatti, "A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy", Neuroscience, vol. 123, no. 3, pp. 585-588, 2004.
100. D. Ribatti, S. Molica, A. Vacca et al., "Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia", Leukemia, vol. 17, no. 7, pp. 1428-1430, 2003.
101. D. Ribatti, M. G. Ennas, A. Vacca et al., "Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma", European Journal of Clinical Investigation, vol. 33, no. 5, pp. 420-425, 2003.
102. V. Goffredo, C. D. Gadaleta, A. Laterza, A. Vacca, and G. Ranieri, "Tryptase serum levels in patients suffering from hepatocellular carcinoma undergoing intra-arterial chemoembolization: possible predictive role of response to treatment", Molecular and Clinical Oncology, vol. 1, no. 2, pp. 385-389, 2013.
103. M. Ammendola, R. Sacco, G. Donato et al., "Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically", Oncology, vol. 85, no. 2, pp. 111-116, 2013.
104. I. Marech, M. Ammendola, R. Sacco et al., "Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: possible translational significance", BMC Cancer, vol. 14, article 534, 2014.
105. I. Marech, M. Ammendola, C. Gadaleta et al., "Possible biological and translational significance of mast cells density in colorectal cancer", The World Journal of Gastroenterology, vol. 20, no. 27, pp. 8910-8920, 2014.
106. T. C. Theoharides, K.-D. Alysandratos, A. Angelidou et al., "Mast cells and inflammation", Biochimica et Biophysica Acta, vol. 1822, no. 1, pp. 21-33, 2012.
107. A. Malfettone, N. Silvestris, C. Saponaro et al., "High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression", Journal of Cellular and Molecular Medicine, vol. 17, no. 8, pp. 1025-1037, 2013.
108. M. Ammendola, Ch. Leporini, I. Marech et al., "Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy", BioMed Research International, vol. 2014, Article ID 154702, 16 pages, 2014.
109. C. M. Kielty, M. Lees, C. A. Shuttleworth, and D. Woolley, "Catabolism of intact type VI collagen microfibrils: susceptibility to degradation by serine proteinases", Biochemical and Biophysical Research Communications, vol. 191, no. 3, pp. 1230-1236, 1993.
110. D. Ribatti and G. Ranieri, "Tryptase, a novel angiogenic factor stored in mast cell granules", Experimental Cell Research, 2014.
111. M. S. Stack and D. A. Johnson, "Human mast cell tryptase activates single-chain urinary-type plasminogen activator (prourokinase)", The Journal of Biological Chemistry, vol. 269, no. 13, pp. 9416-9419, 1994.
112. L. B. Schwartz, T. R. Bradford, B. H. Littman, and B. U. Wintroub, "The fibrinogenolytic activity of purified tryptase from human lung mast cells", Journal of Immunology, vol. 135, no. 4, pp. 2762-2767, 1985.
113. C. Huang, G. W. Wong, N. Ghildyal et al., "The tryptase, mouse mast cell protease 7, exhibits anticoagulant activity in vivo and in vitro due to its ability to degrade fibrinogen in the presence of the diverse array of protease inhibitors in plasma", The Journal of Biological Chemistry, vol. 272, no. 50, pp. 31885-31893, 1997.
114. B. L. Gruber, M. J. Marchese, K. Suzuki et al., "Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation", The Journal of Clinical Investigation, vol. 84, no. 5, pp. 1657-1662, 1989.
115. K. C. Fang, P. J. Wolters, M. Steinhoff, A. Bidgol, J. L. Blount, and G. H. Caughey, "Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta", Journal of Immunology, vol. 162, no. 9, pp. 5528-5535, 1999.
116. T. Sendo, T. Sumimura, Y. Itoh et al., "Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells", Cellular Signalling, vol. 15, no. 8, pp. 773-781, 2003.
117. Y. Itoh, T. Sendo, T. Hirakawa et al., "Role of sensory nerve peptides rather than mast cell histamine in paclitaxel hypersensitivity", The American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 1, pp. 113-119, 2004.
118. R. J. Blair, H. Meng, M. J. Marchese et al., "Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor", The Journal of Clinical Investigation, vol. 99, no. 11, pp. 2691-2700, 1997.
119. S. J. Compton, J. A. Cairns, S. T. Holgate, and A. F. Walls, "The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1β and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells", The Journal of Immunology, vol. 161, no. 4, pp. 1939-1946, 1998.
120. L. M. Coussens, W. W. Raymond, G. Bergers et al., "Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis", Genes and Development, vol. 13, no. 11, pp. 1382-1397, 1999.
121. J. Lohi, I. Harvima, and J. Keski-Oja, "Pericellular substrates of human mast cell tryptase: 72, 000 dalton gelatinase and fibronectin", Journal of Cellular Biochemistry, vol. 50, no. 4, pp. 337-349, 1992.
122. R. Kaminska, P. Helisalmi, R. J. Harvima, A. Naukkarinen, M. Horsmanheimo, and I. T. Harvima, "Focal dermal-epidermal separation and fibronectin cleavage in basement membrane by human mast cell tryptase", Journal of Investigative Dermatology, vol. 113, no. 4, pp. 567-573, 1999.
123. M. Lees, D. J. Taylor, and D. E. Woolley, "Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B", European Journal of Biochemistry, vol. 223, no. 1, pp. 171-177, 1994.
124. W. Zhang, G. Stoica, S. I. Tasca, K. A. Kelly, and C. J. Meininger, "Modulation of tumor angiogenesis by stem cell factor", Cancer Research, vol. 60, no. 23, pp. 6757-6762, 2000.
125. I. A. Akers, M. Parsons, M. R. Hill et al., "Mast cell tryptase stimulates human lung fibroblast proliferation via proteaseactivated receptor-2", The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 278, no. 1, pp. L193-L201, 2000.
126. C. Lu, F. D. Zhao, X. B. Li, and L. H. Yin, "Up-regulation of interleukin-8 expressions induced by mast cell tryptase via protease activated receptor-2 in endothelial cell line", Chinese Medical Journal (English Edition), vol. 118, no. 22, pp. 1900-1906, 2005.
127. X. Zhi, C. Xu, H. Zhang et al., "Tryptase promotes atherosclerotic plaque haemorrhage in ApoE-/-mice", PLoS ONE, vol. 8, no. 4, Article ID e60960, 2013.
128. T. A. McEachron, F. C. Church, and N. MacKman, "Regulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells", Blood Coagulation and Fibrinolysis, vol. 22, no. 7, pp. 576-582, 2011.
129. T. A. McEachron, R. Pawlinski, K. L. Richards, F. C. Church, and N. Mackman, "Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis", Blood, vol. 116, no. 23, pp. 5037-5044, 2010.
130. A. F. Milia, M. B. Salis, T. Stacca et al., "Protease-activated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia", Circulation Research, vol. 91, no. 4, pp. 346-352, 2002.
131. M. Belting, M. I. Dorrell, S. Sandgren et al., "Regulation of angiogenesis by tissue factor cytoplasmic domain signaling", Nature Medicine, vol. 10, no. 5, pp. 502-509, 2004.
132. H. Mirza, V. Yatsula, and W. F. Bahou, "The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells: molecular characterization and evidence for functional coupling to the thrombin receptor", Journal of Clinical Investigation, vol. 97, no. 7, pp. 1705-1714, 1996.
133. C. Cicala, "Protease activated receptor 2 and the cardiovascular system", British Journal of Pharmacology, vol. 135, no. 1, pp. 14-20, 2002.
134. G. M. Hjortoe, L. C. Petersen, T. Albrektsen et al., "Tissue factorfactor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration", Blood, vol. 103, no. 8, pp. 3029-3037, 2004.
135. V. M. Shpacovitch, T. Brzoska, J. Buddenkotte et al., "Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells", Journal of Investigative Dermatology, vol. 118, no. 2, pp. 380-385, 2002.
136. N. Asokananthan, P. T. Graham, J. Fink et al., "Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells", The Journal of Immunology, vol. 168, no. 7, pp. 3577-3585, 2002.
137. Z. H. Wang, W. Zhu, J. P. Tao, Q. Y. Zhang, and M. Wei, "Stimulated mast cells promote maturation of myocardial microvascular endothelial cell neovessels by modulating the angiopoietin-Tie-2 signaling pathway", Brazilian Journal of Medical and Biological Research, vol. 46, no. 11, pp. 920-928, 2013.
138. H. Urata, A. Kinoshita, K. S. Misono, F. M. Bumpus, and A. Husain, "Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart", The Journal of Biological Chemistry, vol. 265, no. 36, pp. 22348-22357, 1990.
139. Y. Kunori, M. Koizumi, T. Masegi et al., "Rodent α-chymases are elastase-like proteases", European Journal of Biochemistry, vol. 269, no. 23, pp. 5921-5930, 2002.
140. U. M. Chandrasekharan, S. Sanker, M. J. Glynias, S. S. Karnik, and A. Husain, "Angiotensin II-forming activity in a reconstructed ancestral chymase", Science, vol. 271, no. 5248, pp. 502-505, 1996.
141. G. H. Caughey, W. W. Raymond, and P. J. Wolters, "Angiotensin II generation by mast cell α- and β-chymases", Biochimica et Biophysica Acta, vol. 1480, no. 1-2, pp. 245-257, 2000.
142. S. Sanker, U. M. Chandrasekharan, D. Wilk, M. J. Glynias, S. S. Karnik, and A. Husain, "Distinct multisite synergistic interactions determine substrate specificities of human chymase and rat chymase-1 for angiotensin II formation and degradation", The Journal of Biological Chemistry, vol. 272, no. 5, pp. 2963-2968, 1997.
143. M. W. Kofford, L. B. Schwartz, N. M. Schechter, D. R. Yager, R. F. Diegelmann, and M. F. Graham, "Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide", The Journal of Biological Chemistry, vol. 272, no. 11, pp. 7127-7131, 1997.
144. K. C. Fang, W. W. Raymond, S. C. Lazarus, and G. H. Caughey, "Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase", The Journal of Clinical Investigation, vol. 97, no. 7, pp. 1589-1596, 1996.
145. E. Tchougounova, A. Lundequist, I. Fajardo, J.-O. Winberg, M. Åbrink, and G. Pejler, "A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2", The Journal of Biological Chemistry, vol. 280, no. 10, pp. 9291-9296, 2005.
146. B. T. Frank, J. C. Rossall, G. H. Caughey, and K. C. Fang, "Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase", Journal of Immunology, vol. 166, no. 4, pp. 2783-2792, 2001.
147. A. Nakano, F. Kishi, K. Minami, H. Wakabayashi, Y. Nakaya, and H. Kido, "Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells", Journal of Immunology, vol. 159, no. 4, pp. 1987-1992, 1997.
148. S. Takai, N. Shiota, D. Jin, and M. Miyazaki, "Chymase processes big-endothelin-2 to endothelin-2-(1-31) that induces contractile responses in the isolated monkey trachea", European Journal of Pharmacology, vol. 358, no. 3, pp. 229-233, 1998.
149. J. Taipale, J. Lohi, J. Saarinen, P. T. Kovanen, and J. Keski-Oja, "Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells", The Journal of Biological Chemistry, vol. 270, no. 9, pp. 4689-4696, 1995.
150. G. Pejler and A. Karlstrom, "Thrombin is inactivated by mast cell secretory granule chymase", The Journal of Biological Chemistry, vol. 268, no. 16, pp. 11817-11822, 1993.
151. G. H. Caughey, "New developments in the genetics and activation of mast cell proteases", Molecular Immunology, vol. 38, no. 16-18, pp. 1353-1357, 2002.
152. L. Lindstedt, M. Lee, and P. T. Kovanen, "Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid", Atherosclerosis, vol. 155, no. 1, pp. 87-97, 2001.
153. H. Urata, S. Hoffmann, and D. Ganten, "Tissue angiotensin II system in the human heart", European Heart Journal, vol. 15, pp. 68-78, 1994.
154. T. Terada and Y. Matsunaga, "Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma", Journal of Hepatology, vol. 33, no. 6, pp. 961-966, 2000.
155. S.-Y. Tan, Y. Fan, H.-S. Luo, Z.-X. Shen, Y. Guo, and L.-J. Zhao, "Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer", World Journal of Gastroenterology, vol. 11, no. 8, pp. 1210-1214, 2005.
156. A. Cabanillas-Saez, J. A. Schalper, S. M. Nicovani, and M. I. Rudolph, "Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix", International Journal of Gynecological Cancer, vol. 12, no. 1, pp. 92-98, 2002.
157. M. Muramatsu, J. Katada, I. Hayashi, and M. Majima, "Involvement of chymase in angiogenesis in hamster sponge granulomas", Nihon Yakurigaku Zasshi, vol. 114, supplement 1, pp. 48P-54P, 1999.
158. M. Muramatsu, M. Yamada, S. Takai, and M. Miyazaki, "Suppression of basic fibroblast growth factor-induced angiogenesis by a specific chymase inhibitor, BCEAB, through the chymaseangiotensin-dependent pathway in hamster sponge granulomas", British Journal of Pharmacology, vol. 137, no. 4, pp. 554-560, 2002.
159. J. Katada, M. Muramatsu, I. Hayashi, M. Tsutsumi, Y. Konishi, and M. Majima, "Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas", The Journal of Pharmacology and Experimental Therapeutics, vol. 302, no. 3, pp. 949-956, 2002.
160. J. M. Arbeit, K. Münger, P. M. Howley, and D. Hanahan, "Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice", Journal of Virology, vol. 68, no. 7, pp. 4358-4368, 1994.
161. L. M. Coussens and Z. Werb, "Matrix metalloproteinases and the development of cancer", Chemistry and Biology, vol. 3, no. 11, pp. 895-904, 1996.
162. E. I. Deryugina and J. P. Quigley, "Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions", Biochimica et Biophysica Acta, vol. 1803, no. 1, pp. 103-120, 2010.
163. A. Russo, G. Russo, M. Peticca, C. Pietropaolo, M. Di Rosa, and T. Iuvone, "Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5", British Journal of Pharmacology, vol. 145, no. 1, pp. 24-33, 2005.
164. I. G. Rojas, M. L. Spencer, A. Martínez, M. A. Maurelia, and M. I. Rudolph, "Characterization of mast cell subpopulations in lip cancer", Journal of Oral Pathology and Medicine, vol. 34, no. 5, pp. 268-273, 2005.
165. M. Bialas, G. Dyduch, J. Szpor, S. Demczuk, and K. Okoń, "Microvascular density and mast cells in benign and malignant pheochromocytomas", Polish Journal of Pathology, vol. 63, no. 4, pp. 235-242, 2012.
166. T. Globa, L. Şaptefrţi, R. A. Ceauşu, P. Gaje, A. M. Cimpean, and M. Raica, "Mast cell phenotype in benign and malignant tumors of the prostate", Polish Journal of Pathology, vol. 2, pp. 147-153, 2014.
167. M. Wilk, Ł. Liszka, P. Paleń, A. Gabriel, and P. Laudański, "Intensity of angiogenesis and mast cell infiltration in cervical intraepithelial and invasive lesions-are they correlated?" Pathology Research and Practice, vol. 206, no. 4, pp. 217-222, 2010.
168. M. Nagata, N. Shijubo, A. F. Walls, S. Ichimiya, S. Abe, and N. Sato, "Chymase-positive mast cells in small sized adenocarcinoma of the lung", Virchows Archiv, vol. 443, no. 4, pp. 565-573, 2003.
169. S. T. Tan, R. A. Wallis, Y. He, and P. F. Davis, "Mast cells and hemangioma", Plastic and Reconstructive Surgery, vol. 113, no. 3, pp. 999-1011, 2004.